Comparison of the curative effect and safety of rifapentine and rifampicin in smear positive pulmonary tuberculosis patients
10.3969/j.issn.1005-1678.2017.04.115
- VernacularTitle:利福喷丁和利福平在涂阳肺结核患者中的疗效及安全性比较
- Author:
Tuxiang CHEN
;
Yong WANG
;
Zhiping CHEN
- Keywords:
tuberculosis;
rifapentine;
rifampin;
treatment;
complication rate
- From:
Chinese Journal of Biochemical Pharmaceutics
2017;37(4):348-350
- CountryChina
- Language:Chinese
-
Abstract:
Objective To compare the clinical therapeutic effect and safety of rifapentine and rifampicin in smear positive pulmonary tuberculosis patients.Methods A total of 80 patients with smear positive pulmonary tuberculosis were chosen in Changshan People's Hospital from June 2015 to July 2016,the patients were randomly divided into control group(n=40)and observation group(n=40).The control group used rifampicin treatment,observation group were treated with rifapentine therapy,the therapeutic effect and incidence of complications between two groups were compared.Results Proportion of the sputum smear negative,cavity closure and lesions absorption in the observation group after 6 months of treatment were significantly higher than those in the control group; peripheral blood T lymphocyte subsets CD3+,CD4+,CD8+ levels in two groups before treatment had no statistically significant differences; peripheral blood of T lymphocyte subsets CD3+,CD4+,CD8+ levels in the observation group after treatment were significantly higher than those in the control group(P<0.05); incidence of complications in observation group(7.5％)after treatment was significantly lower than that in the control group(17.5％)(P<0.05).Conclusion Compared with rifampicin in treatment of smear positive pulmonary tuberculosis patients,rifapentine has ideal treatment effect,can improve the immune function,low incidence of complications.
